Impact of preexisting mental illness on breast cancer endocrine therapy adherence.
Cole B HaskinsBradley D McDowellRyan M CarnahanJess G FiedorowiczRobert B WallaceBrian J SmithElizabeth A ChrischillesPublished in: Breast cancer research and treatment (2018)
Nearly one-quarter of female Medicare beneficiaries have diagnosed mental illness preceding invasive breast cancer. Those with certain mental illnesses have modestly reduced rates of initiation, adherence, and discontinuation and this may help define patients at higher risk of treatment abandonment. Overall, endocrine therapy adherence remains suboptimal, unnecessarily worsening recurrence and mortality risk.